{"id":24145,"date":"2025-06-26T07:20:38","date_gmt":"2025-06-26T05:20:38","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/geopolitica-dellintelligenza-artificiale\/"},"modified":"2025-07-04T14:21:22","modified_gmt":"2025-07-04T12:21:22","slug":"geopolitica-dellintelligenza-artificiale","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/","title":{"rendered":"Geopolitics of artificial intelligence"},"content":{"rendered":"

Artificial intelligence ceased to be merely a field of technological research long ago. It has become a strategic axis of global competition<\/strong>, with far-reaching implications across science, economics, and politics. According to the picture outlined by the <\/span>2025 AI Index Report<\/a>,<\/span><\/i> AI thinks Chinese but acts American. <\/strong><\/span>On the global stage, the center of scientific production is shifting eastward: in 2023, the Asia-Pacific region accounted for over a third of the world\u2019s AI publications (34.5%), with China leading at over 23%\u2014well ahead of the United States (9.2%) and Europe (15.2%).<\/span><\/p>\n

On the production side, however, the balance shifts.<\/strong> In 2024, the United States generated 40 of the so-called notable AI models<\/em>, compared to China’s 15. Since 2003, no other country has produced more cutting-edge innovations. This technical leadership is matched by financial dominance: with over $109 billion invested in 2024 alone (a +50.7% increase from the previous year), the U.S. confirms its role as the economic epicenter, compared to $9.3 billion in the Chinese market (a -1.9% decrease). Europe performs slightly better, with over $19 billion in investments (+60%).<\/p>\n

The geopolitical landscape of AI<\/strong>, however, is made far more complex by a supply chain that spans multiple continents and involves\u2014not just the two superpowers\u2014but also numerous other nations such as India, Taiwan, Mexico, Malaysia, South Korea, Japan, the United Kingdom, and the European Union.<\/p>\n

We discuss this with <\/span>Alessandro Aresu<\/a> \u2013 writer, consultant, and expert in public policy, strategy, and geopolitics \u2013 as well as author of the recently published essay “Geopolitica dell’intelligenza artificiale”.<\/span><\/p>\n

How does the race for AI fit into the current geopolitical context?<\/strong>
<\/b><\/p>\n

We have long been living through a process I define as \u201cpolitical capitalism\u201d<\/em>, in which the competition between the United States and China\u2014at least since the launch of China\u2019s Made in China 2025<\/em> plan in 2015\u2014has led to an increasing intertwining of market goals and political objectives, with national security expanding into various technological sectors.
If we follow the trajectory of major global tech companies over the past decade\u2014studying, for example, entities like ASML, BYD, DeepMind, NVIDIA, Palantir, and TSMC\u2014we increasingly see that they must take political issues and geopolitical risks into account, from tariffs and sanctions to export controls<\/strong>.
Artificial intelligence is fully embedded in this dynamic and cannot be understood outside of this broader context.<\/span><\/p>\n

What\u2019s at stake geopolitically?<\/strong><\/b><\/p>\n

First of all, artificial intelligence is not a separate domain, but part of the broader evolution of digitalization and the semiconductor industry<\/strong>. To “build” AI, we need what NVIDIA has long described as “factories of artificial intelligence”<\/em>\u2014that is, data centers, a concept the company has developed over many years and which has led to the creation of its advanced systems.
At the same time, these data centers depend on “factories of the factories of artificial intelligence”<\/em>: the places where semiconductors are produced\u2014such as Taiwan Semiconductor Manufacturing Company\u2014along with Korean and U.S. memory manufacturers, Taiwanese assemblers, the chemical industry, industrial gases, steel, copper, energy, and much more.
The control and organization of this supply chain, which is far more complex than that of software companies, is the central and most critical issue.<\/p>\n

The main drivers of geopolitical dynamics are the geography of talent<\/em>\u2014that is, where STEM talents are educated, in which universities or research centers they work, and which companies they join\u2014and the structure of computing infrastructures<\/em>: namely, the full range of capabilities tied to the semiconductor industry, its ecosystem, and the development of data centers.<\/p>\n

The main competitors today are the U.S. and China: what are their goals?<\/strong><\/p>\n

Technological leadership\u2014in so-called foundational or emerging technologies\u2014has always gone hand in hand with political leadership in the international system.
Each of the major contenders is therefore pursuing the AI race to maintain or enhance its global standing, as well as to ensure the deployment of these technologies in military and industrial domains.
This is true for both the United States and China\u2014despite their very different political systems\u2014but it also applies to other players, such as India and the Gulf monarchies, for example.<\/b><\/p>\n

What are the strengths and weaknesses of the two superpowers?<\/strong><\/p>\n

As I also point out in my book\u2014where I go into more detail\u2014the U.S. has a stronger ability to attract talent and capita<\/strong>l.
China, on the other hand, is the world\u2019s largest producer of talent and is an industrial power far superior to the U.S.\u2014and industrial capacity still matters, even in this field.
Beyond these two, India is also a major player in the global talent landscape<\/strong>. Just look at the number of university students, managers, and entrepreneurs of Indian origin in the United States.
In this scenario\u2014where strengths and weaknesses differ\u2014it\u2019s hard to imagine one side gaining any kind of definitive leadership, especially in an increasingly complex and fragmented world.<\/p>\n

In all this, the European Union remains significantly behind\u2014more focused on setting rules than on advancing technological development. Is that a good strategy?<\/strong><\/p>\n

Essentially, it\u2019s a pointless strategy. Not necessarily harmful, but pointless\u2014because the idea that Europe\u2019s regulatory capacity has real global influence is simply false, and certainly overestimated.
I\u2019ve written about this many times: I\u2019ve explained everything there is to know about Europe\u2019s position in the technological race.
Competition is about talent, capital, and companies\u2014so what matters are the regulations that affect those three factors. The rest is just noise.
Europe is already a region in decline in this century. So unless it improves in those three areas, the decline will only deepen. Period.<\/span><\/p>\n

Is a full-blown confrontation really possible in such an interconnected world?<\/strong><\/p>\n

It\u2019s very difficult\u2014but it\u2019s still being pursued. The result is a series of bold moves, often later revised or adjusted, aimed at reshaping the geography of value chains\u2014because that very geography holds political value.
We\u2019ve already seen this during the first Trump administration, with the reduction of some areas of direct exchange between Beijing and Washington, and the growing importance of alternative production and trade geographies\u2014first and foremost, Southeast Asian countries like Vietnam and Malaysia, as well as Mexico, which is playing an increasingly central role, and of course India.
One essential point to understand is that a full-scale U.S. trade war against the entire world is essentially impossible\u2014just as a complete and consistent reindustrialization of the United States is unlikely.
What can<\/em> happen, however, is a push toward value chains that aim to exclude\u2014though with difficulty\u2014China, along with the reshoring of certain production segments back to the U.S.<\/p>\n

What are the most likely global scenarios for the future?<\/strong><\/p>\n

The Silicon Valley crowd will keep throwing out “decisive dates”\u2014like 2027\u2014with the sole aim of making money, and with a fair amount of success.
Meanwhile, artificial intelligence will remain a complex and multifaceted supply chain<\/strong>, where what really matters is control over its key nodes and its diffusion across various industrial sectors.
The data center economy won\u2019t be able to sustain the same growth rates indefinitely, so companies will increasingly shift toward robotics and its many applications\u2014as we\u2019re already seeing\u2014but also toward biotechnology.
In any case, the driving forces behind this process will remain the same: talent, companies, capital.<\/p>\n

In this context, what should life science companies expect?<\/strong><\/p>\n

First of all, as demonstrated by the 2024 Nobel Prize in Chemistry awarded to Demis Hassabis and others for AlphaFold, it\u2019s clear that biology and biotechnology are already areas of significant interest for companies working in artificial intelligence<\/strong>.
For life science companies, the key issue to monitor is how scientific breakthroughs might translate into commercial returns. That means keeping a close eye on initiatives like Isomorphic Labs\u2014a subsidiary of Alphabet (Google\u2019s parent company) founded in 2021 to turn DeepMind innovations, especially AlphaFold, into real-world drug discovery solutions.
It also means paying attention to the promises of the Stargate Project<\/em>\u2014a joint venture launched this year by OpenAI, SoftBank, Oracle, and the MGX fund, aiming to invest up to $500 billion in AI infrastructure over the next four years.
NVIDIA, the leading force in the AI ecosystem, is already making major investments in life sciences\u2014this alone shows just how crucial the field has become.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

AI is an intertwined and hyper-politicized global supply chain, where science, industry and geopolitics merge in a competition for the control of strategic nodes, from silicon to talent, from models to algorithms<\/p>\n","protected":false},"author":4,"featured_media":23986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[837,1101],"tags":[],"class_list":{"0":"post-24145","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"category-highlights-en"},"yoast_head":"\nGeopolitics of artificial intelligence - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geopolitics of artificial intelligence - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-26T05:20:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-04T12:21:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Simone Montonati\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simone Montonati\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\"},\"author\":{\"name\":\"Simone Montonati\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428\"},\"headline\":\"Geopolitics of artificial intelligence\",\"datePublished\":\"2025-06-26T05:20:38+00:00\",\"dateModified\":\"2025-07-04T12:21:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\"},\"wordCount\":1377,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png\",\"articleSection\":[\"Artificial intelligence\",\"HIGHLIGHTS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\",\"name\":\"Geopolitics of artificial intelligence - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png\",\"datePublished\":\"2025-06-26T05:20:38+00:00\",\"dateModified\":\"2025-07-04T12:21:22+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428\"},\"description\":\"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geopolitics of artificial intelligence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428\",\"name\":\"Simone Montonati\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"caption\":\"Simone Montonati\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/simone-montonati\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geopolitics of artificial intelligence - MakingPharmaIndustry","description":"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/","og_locale":"en_US","og_type":"article","og_title":"Geopolitics of artificial intelligence - MakingPharmaIndustry","og_description":"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes","og_url":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-06-26T05:20:38+00:00","article_modified_time":"2025-07-04T12:21:22+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48-1024x683.png","type":"image\/png"}],"author":"Simone Montonati","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Simone Montonati","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/"},"author":{"name":"Simone Montonati","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428"},"headline":"Geopolitics of artificial intelligence","datePublished":"2025-06-26T05:20:38+00:00","dateModified":"2025-07-04T12:21:22+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/"},"wordCount":1377,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png","articleSection":["Artificial intelligence","HIGHLIGHTS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/","url":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/","name":"Geopolitics of artificial intelligence - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png","datePublished":"2025-06-26T05:20:38+00:00","dateModified":"2025-07-04T12:21:22+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428"},"description":"AI, in the global supply chain, science, industry and geopolitics come together in a competition for the control of strategic nodes","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-24-giu-2025-12_35_48.png","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/geopolitica-dellintelligenza-artificiale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Geopolitics of artificial intelligence"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/7f5c7bab24683ca938bb370ccf190428","name":"Simone Montonati","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","caption":"Simone Montonati"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/simone-montonati\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=24145"}],"version-history":[{"count":3,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24145\/revisions"}],"predecessor-version":[{"id":24149,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24145\/revisions\/24149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/23986"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=24145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=24145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=24145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}